PHARMA MAR
ActiveSummary
PHARMA MAR has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €223,426 and a net result of €8,208. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 46% of 93 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Board 2
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Elena CALLEJA CRESPO |
|
| Luis MORA CAPITAN |
|
| KPMG Réviseurs d'Entreprises |
|
Owners and capital
Owners
1 ownerChain of control
- Pharma Mar S.A.ES
- PHARMA MAR
Highest known parent: Pharma Mar S.A. (Spain). The sources do not say who stands above it.
Owners 1
- Pharma Mar S.A.ESparentSourceown accounts 2025100%
According to the 2025 annual accounts of PHARMA MAR and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 21-11-2023 Converted to unavailable equity · €150,000